DIAGNOSTIC_TEST · Unmapped registry intervention
blood draw
Find medicine records ·
Find other trials using this name
Clinical trial
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
NCT06122077
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedClinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Lung Cancer Diagnosisunresolved
Interventions
blood drawDIAGNOSTIC_TEST
Sponsors & collaborators
Freenome Holdings Inc.lead sponsor
Mapped research locations
HoustonTexas, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1PortlandOregon, United States1Oklahoma CityOklahoma, United States1CharlestonSouth Carolina, United States1MilwaukeeWisconsin, United States1RaleighNorth Carolina, United States1WichitaKansas, United States1SpringfieldIllinois, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06122077 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.